Clinical Trials
5 trialsNCT05907759 2026-06-02
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT07308886 2026-05-08
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT06445166 2026-04-06
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Phase 2 Recruiting
NCT04305691 2026-02-27
Trial of Ixazomib for Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Recruiting